IperionX Limited (ASX: IPX) - Share Price

- Current share price for IPX : $3.070

IperionX Limited (IPX, formerly Hyperion Metals Limited), an ASX-listed company, is an American producer of titanium alloys, titanium products, and critical minerals, using patented metal technologies to produce performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions. Founded in 2020, It is a public company listed on both the Nasdaq and the ASX.

IPX General Information ⁺

ASX Code	IPX
Website	N/A
Industry/Sector	Precious Metals & Minerals
Market Cap ($M)	1,112
IPX Share Price	$3.070
Day High	$3.200
Day Low	$3.070
Last Close	$3.070
IPX Share Price Movement	- ( No change )

Prices as at 16:40, 24 Jul 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

IperionX Limited (IPX) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
Final	3¢	100%	18 Nov 2008	16 Dec 2008	-	-	-

See all dividends from IperionX Limited (IPX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

IperionX Limited (IPX) price-sensitive announcements

IPX - IperionX Offering of American Depositary Shares

IperionX Limited has announced the pricing of a public offering of 2,275,000 American Depo

IperionX Limited (IPX)
8 Jul 2026 | 9:57 AM

IPX - Acquisition Delivers High Value Critical Minerals

IperionX Limited announced the completion of its strategic acquisition of the Camden site,

IperionX Limited (IPX)
2 Jul 2026 | 9:19 AM

IPX - IperionX Awarded up to US$6.6M for Titanium Plate

IperionX Limited has been awarded up to US$6.6 million under the U.S. Department of War's

IperionX Limited (IPX)
1 Jul 2026 | 8:56 AM

IPX - IperionX to Consolidate Big Sandy Critical Mineral Province

IperionX Limited has announced the acquisition of key assets from Covia Solutions LLC’s Ca

IperionX Limited (IPX)
15 Jun 2026 | 8:40 AM

IperionX Limited (IPX) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
IperionX Limited (IPX) ORDINARY FULLY PAID	Materials	$1,112	Change in substantial holding	21 Jul 2026 5:13PM	$3.230	$3.070	fallen by 4.95%
IperionX Limited (IPX) ORDINARY FULLY PAID	Materials	$1,112	Change of Director's Interest Notice x 2	15 Jul 2026 11:55AM	$3.675	$3.070	fallen by 16.46%
IperionX Limited (IPX) ORDINARY FULLY PAID	Materials	$1,112	Notice under Section 708A	15 Jul 2026 11:44AM	$3.660	$3.070	fallen by 16.12%
IperionX Limited (IPX) ORDINARY FULLY PAID	Materials	$1,112	Application for quotation of securities - IPX	15 Jul 2026 11:40AM	$3.660	$3.070	fallen by 16.12%
IperionX Limited (IPX) ORDINARY FULLY PAID	Materials	$1,112	Change of Director's Interest Notice x 3	14 Jul 2026 8:53AM	$3.550	$3.070	fallen by 13.52%
IperionX Limited (IPX) ORDINARY FULLY PAID	Materials	$1,112	Change in substantial holding	13 Jul 2026 8:24AM	$3.590	$3.070	fallen by 14.48%

IPX Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2027F	C2	-$5.70	-64.00%	0.00%	0.0%
2026F	C2	-$16.00	-12.30%	0.00%	0.0%
2025A	-$53.97	-$18.20	21.30%	0.00%	0.0%

IPX Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2025 A	2026 F	2027 F	2025 A	2026 F	2027 F	2025 A	2026 F	2027 F
IperionX Limited (IPX)	$1,206M	0.2128	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%

IPX Directors

Name	Position	Start Date
Mr Anastasios (Taso) Arima	Chief Executive Officer, Founder, Executive Director, Managing Director	1 Dec 2020
Mr Todd William Hannigan	Executive Chairman, Executive Director	1 Feb 2021
Mr Vaughn Taylor	Non-Executive Director	3 Mar 2021
Ms Melissa G Waller	Non-Executive Director	13 Sep 2021
Ms Beverly M Wyse	Non-Executive Director	13 Sep 2021
Mr R Tony Tripeny	Non-Executive Director	17 Mar 2025
Ms Lorraine M Martin	Non-Executive Director, Lead Independent Director.	13 Sep 2021

IperionX Limited (IPX) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
15 Jul 2026	WYSE, Beverly	Buy	Direct Shares	106,093	$0.870	$92,300.910
15 Jul 2026	WYSE, Beverly	Exercise	Options	106,093	$0.870	$92,300.910
14 Jul 2026	TRIPENY, R	Buy	Direct Shares	38,460	$2.600	$99,996.000

See all changes in directors' interest & trades for IperionX Limited (IPX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IPX Management

Name	Position
Dominic P Allen	Chief Commercial Officer
Marcela Castro	Chief Financial Officer
W Scott Sparks	Chief Operating Officer
Louisa Anne Martino (Youens)	Company Secretary
Toby E Symonds	President and Chief Strategy Officer

IPX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in IperionX Limited (IPX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
45,802,651 (13.72%)	The Bank of New York Mellon Corporation
26,097,578 (7.81%)	FMR LLC and and the entities
25,443,775 (7.61%)	DITM Holdings Pty Ltd

IPX Calendar of Events

Date	Event
26 April 2027	Report (Quarterly)
29 January 2027	Report (Quarterly)
29 October 2026	Report (Quarterly)
29 September 2026	Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us